About: FGFR4 prevents hyperlipidemia and insulin resistance but underlies high-fat diet induced fatty liver

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: FGFR4 prevents hyperlipidemia and insulin resistance but underlies high-fat diet induced fatty liver Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific journal article

Attributes	Values
rdf:type	Item
description	artículu científicu espublizáu en 2007 (ast) vědecký článek publikovaný v roce 2007 (cs) 2007 թվականի հոտեմբերին հրատարակված գիտական հոդված (hy) наукова стаття, опублікована в жовтні 2007 (uk) 2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած (hyw) vedecký článok (publikovaný 2007/10/01) (sk) مقالة علمية (نشرت في أكتوبر 2007) (ar) wetenschappelijk artikel (gepubliceerd op 2007/10/01) (nl) article scientifique publié en 2007 (fr) im Oktober 2007 veröffentlichter wissenschaftlicher Artikel (de) scientific journal article (en)
publication date	wds:Q28512989-2DB3B3AF-8FE6-4B1A-B631-CC3EBF8C6BD1
publication date	2007-10-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q28512989-547DB45B-0EB2-448D-88F6-76DDCB89123D
language of work or name	English
author name string	wds:Q28512989-12B6CA09-8835-4059-8E00-9AD215F0C1D5 wds:Q28512989-5ABBBD3D-6B0C-4BAF-B90A-EC29645217A3 wds:Q28512989-90E313AA-E160-4EF4-AE55-1F373198DBC5 wds:Q28512989-9D7EA182-E72E-461D-8278-D4459094B417 wds:Q28512989-9F38B37A-B970-495D-B3EA-F9A62A20CD69 wds:Q28512989-B8EAE81C-FB6D-40BC-AB6C-B4663C73DF98
author name string	Chengliu Jin Fen Wang Chaofeng Yang Wallace L. McKeehan Xinqiang Huang Yongde Luo
rdfs:label	FGFR4 prevents hyperlipidemia and insulin resistance but underlies high-fat diet induced fatty liver (en) FGFR4 prevents hyperlipidemia and insulin resistance but underlies high-fat diet induced fatty liver (nl) FGFR4 prevents hyperlipidemia and insulin resistance but underlies high-fat diet induced fatty liver (ast)
skos:prefLabel	FGFR4 prevents hyperlipidemia and insulin resistance but underlies high-fat diet induced fatty liver (en) FGFR4 prevents hyperlipidemia and insulin resistance but underlies high-fat diet induced fatty liver (nl) FGFR4 prevents hyperlipidemia and insulin resistance but underlies high-fat diet induced fatty liver (ast)
name	FGFR4 prevents hyperlipidemia and insulin resistance but underlies high-fat diet induced fatty liver (en) FGFR4 prevents hyperlipidemia and insulin resistance but underlies high-fat diet induced fatty liver (nl) FGFR4 prevents hyperlipidemia and insulin resistance but underlies high-fat diet induced fatty liver (ast)
title	wds:Q28512989-572B7584-BFC2-4DD2-8F0F-B0E02F25344C
title	FGFR4 prevents hyperlipidemia and insulin resistance but underlies high-fat diet induced fatty liver (en)
page(s)	wds:Q28512989-D0423727-1F0B-4C09-99BD-67668E5455BC
page(s)	2501–2510
instance of	wds:Q28512989-AFE81535-99C0-4A0B-9403-63B8138EC948
instance of	scholarly article
main subject	wds:Q28512989-669D8558-AACC-4FAC-81F5-8DF918729206 wds:Q28512989-6B68D5EE-243B-4515-A457-F075F6D925D5 wds:Q28512989-768577E0-2B2C-4E6C-8B9A-8607880793F7 wds:Q28512989-A5E083C9-2FFA-489D-99ED-1A0D2F1625DD
main subject	insulin resistance hyperlipidemia wd:Q7240673 Fibroblast growth factor receptor 4
PubMed ID	wds:Q28512989-B33050E4-1E56-470A-9EA5-04BAE7B7DBA4
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/17664243
PubMed ID	17664243
published in	wds:Q28512989-08ADC0F6-88B5-4785-8AB7-C34DC4D40C4A
published in	Diabetes
issue	wds:Q28512989-C9A5E125-F6FE-4553-9DAB-E473544512C8
volume	wds:Q28512989-9285A866-17B4-4447-9584-D62674277DB7
issue	10
volume	56
DOI	wds:Q28512989-D6E880D5-28E5-4B16-B06B-D95D54163612
DOI	http://dx.doi.org/10.2337/DB07-0648
DOI	10.2337/DB07-0648
Fatcat ID	wds:Q28512989-49FC4EEA-3B24-4F51-B85A-F017533D3D49
Fatcat ID	release_htwjv7lsefbknmbzxycznn6q4i
ResearchGate publication ID	wds:Q28512989-AD74DC45-3CBB-4345-945A-1FAA4174AF0F
ResearchGate publication ID	6175393
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q28512989
is cites work of	Endocrine fibroblast growth factors 15/19 and 21: from feast to famine FGF19 action in the brain induces insulin-independent glucose lowering Impact of new-generation lipid emulsions on cellular mechanisms of parenteral nutrition-associated liver disease Hepatocyte FRS2α is essential for the endocrine fibroblast growth factor to limit the amplitude of bile acid production induced by prandial activity The metabolic syndrome New genetic loci link adipose and insulin biology to body fat distribution Minireview: Roles of Fibroblast Growth Factors 19 and 21 in Metabolic Regulation and Chronic Diseases Selective activation of FGFR4 by an FGF19 variant does not improve glucose metabolism in ob/ob mice Differential specificity of endocrine FGF19 and FGF21 to FGFR1 and FGFR4 in complex with KLB. FGF15/FGFR4 integrates growth factor signaling with hepatic bile acid metabolism and insulin action LXR ligand lowers LDL cholesterol in primates, is lipid neutral in hamster, and reduces atherosclerosis in mouse Metabolic regulator betaKlotho interacts with fibroblast growth factor receptor 4 (FGFR4) to induce apoptosis and inhibit tumor cell proliferation Bitter melon extract attenuating hepatic steatosis may be mediated by FGF21 and AMPK/Sirt1 signaling in mice FGF15/19 regulates hepatic glucose metabolism by inhibiting the CREB-PGC-1α pathway Fundamentals of FGF19 & FGF21 action in vitro and in vivo Resident hepatocyte fibroblast growth factor receptor 4 limits hepatocarcinogenesis Role of FGF19 induced FGFR4 activation in the regulation of glucose homeostasis The Fibroblast Growth Factor signaling pathway FGF19 regulates cell proliferation, glucose and bile acid metabolism via FGFR4-dependent and independent pathways Peripheral reduction of FGFR4 with antisense oligonucleotides increases metabolic rate and lowers adiposity in diet-induced obese mice Enteral bile acid treatment improves parenteral nutrition-related liver disease and intestinal mucosal atrophy in neonatal pigs Activation of Liver FGF21 in hepatocarcinogenesis and during hepatic stress Control of lipid metabolism by adipocyte FGFR1-mediated adipohepatic communication during hepatic stress Deficiency of metabolic regulator FGFR4 delays breast cancer progression through systemic and microenvironmental metabolic alterations Fibroblast growth factor-19 action in the brain reduces food intake and body weight and improves glucose tolerance in male rats. The heteromeric organic solute transporter, OSTα-OSTβ/SLC51: a transporter for steroid-derived molecules Diet, behavior and immunity across the lifespan. Reduction of glycosphingolipid biosynthesis stimulates biliary lipid secretion in mice Targeting fibroblast growth factor 19 in liver disease: a potential biomarker and therapeutic target. Interferon regulatory factor 7 deficiency prevents diet-induced obesity and insulin resistance Pubertal high fat diet: effects on mammary cancer development. Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software